Predicting Inpatient Status After Primary Total Knee Arthroplasty in Medicare-Aged Patients

Christian Gronbeck1, Mark P Cote2, Mohamad J Halawi2

  • 1University of Connecticut School of Medicine, Farmington, CT.

Insights

A new nomogram helps identify Medicare patients needing inpatient admission for total knee arthroplasty (TKA) after its removal from inpatient-only lists. Key factors include age, functional status, and comorbidities, aiding clinical decisions.

Area of Science:

  • Orthopedic Surgery
  • Health Services Research
  • Geriatric Medicine

Background:

  • Total knee arthroplasty (TKA) was removed from the inpatient-only (IPO) list by the Centers for Medicare and Medicaid Services (CMS) effective January 1, 2018.
  • This policy change necessitates a method to determine appropriate inpatient admission for Medicare-aged patients undergoing TKA.

Purpose of the Study:

  • To develop a risk-stratifying nomogram for Medicare-aged patients undergoing primary TKA.
  • To aid clinicians in deciding the necessity of inpatient admission post-TKA.

Main Methods:

  • Utilized the American College of Surgeons National Surgical Quality Improvement Program database (2006-2015).
  • Included patients aged 65 years and older undergoing primary TKA.
  • Employed multivariate logistic regression to identify predictors of inpatient admission (defined as >2 days length of stay).

Main Results:

  • Analyzed over 87,000 TKA admissions (61,284 inpatient, 26,066 outpatient).
  • Significant predictors of inpatient stay included age >80, simultaneous bilateral TKA, dependent functional status, metastatic cancer, and female gender.
  • The developed predictive model showed good discrimination and calibration.

Conclusions:

  • The established nomogram reliably identifies suitable candidates for inpatient admission among Medicare-aged TKA patients.
  • Further multicenter studies are recommended for external validation of the predictive nomogram.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
193
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
266
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
239
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
203
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
245
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.6K